Latigo Biotherapeutics Inc
D

LTGO

15.220
USD
0.25
(1.67%)
مغلق
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
9,624
الربح لكل سهم
0
العائد الربحي
-
P/E
-8
حجم السوق
1,009,076,061

العنوان: Latigo Biotherapeutics Inc

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Latigo Biotherapeutics Inc is a clinical-stage biotechnology company focused on developing non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its flagship product candidates, LTG-001 and LTG-321, are oral Nav1.8 inhibitors being developed for the treatment of acute pain. The company is also developing additional Nav1.8 inhibitor candidates using alternative formulations and delivery approaches.